Montclair, NJ
1 Bay Avenue, Ste. 2
Montclair NJ 07042
Montclair NJ 07042
mon-fri8:00 AM - 4:30 PM
saturdayClosed
sundayClosed
New Patients: For your convenience, please download, print out and complete the New Patient and Patient Medical History Forms and bring to your initial visit.
PATIENT FORMS
- General Consent for RCCA Services
- ACP Screener
- Pharmacy and Prescription Benefit Plan Information Form
- HIPAA acknowledgement
- Consultation Checklist & Radiology Policy
- New Jersey Immunization Information Systems (NJIIS) Consent to Participate
- Autorización de inscripción en el sistema de información sobre vacunación de nueva jersey
- Patient Finanical Assistance
Cancer Treatment Center in
Montclair, NJ
Regional Cancer Care Associates (RCCA) is your local provider of cutting-edge cancer and blood disorder treatments in Montclair, NJ. Our clinic is part of an extensive network of state-of-the-art RCCA clinics located throughout New Jersey, Connecticut, Maryland, and the Washington, DC area. More than 250,000 patients have benefited from our comprehensive, compassionate care.
We understand the impact a cancer diagnosis can have on a person and his or her loved ones, and we are committed to providing highly individualized, “whole person” care. Further, by offering the latest therapies and access to clinical trials in a conveniently located, community-based setting, we eliminate the stress of having to travel to New York City, Philadelphia, or beyond for treatment. Get in touch with the experts at Regional Cancer Care Associates in Montclair, NJ today.
Contact Us for More Information
Schedule an appointment at our office at 1 Bay Ave, Ste 2 Montclair NJ, 07042. You can get in touch with us through our online form.
Regional Cancer Care Associates of Montclair, NJ provides:
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.